ABSTRACT
Increased global connectivity has catalyzed technological development in almost all industries, in part through the facilitation of novel collaborative structures. Notably, open innovation and crowd-sourcing-of expertise and/or funding-has tremendous potential to increase the efficiency with which biomedical ecosystems interact to deliver safe, efficacious and affordable therapies to patients. Consequently, such practices offer tremendous potential in advancing development of cellular therapies. In this vein, the CASMI Translational Stem Cell Consortium (CTSCC) was formed to unite global thought-leaders, producing academically rigorous and commercially practicable solutions to a range of challenges in pluripotent stem cell translation. Critically, the CTSCC research agenda is defined through continuous consultation with its international funding and research partners. Herein, initial findings for all research focus areas are presented to inform global product development strategies, and to stimulate continued industry interaction around biomanufacturing, strategic partnerships, standards, regulation and intellectual property and clinical adoption.
Subject(s)
Cell- and Tissue-Based Therapy , Pluripotent Stem Cells , Stem Cell Research/legislation & jurisprudence , Humans , Intellectual Property , Translational Research, Biomedical/legislation & jurisprudenceABSTRACT
The New York Stem Cell Foundation's "Sixth Annual Translational Stem Cell Research Conference" convened on October 11-12, 2011 at the Rockefeller University in New York City. Over 450 scientists, patient advocates, and stem cell research supporters from 14 countries registered for the conference. In addition to poster and platform presentations, the conference featured panels entitled "Road to the Clinic" and "The Future of Regenerative Medicine."
Subject(s)
Hematopoietic Stem Cells/physiology , Stem Cell Research , Stem Cell Transplantation , Diabetes Mellitus/therapy , Heart Diseases/therapy , Humans , Muscular Diseases/therapy , Neoplasms/therapy , Nervous System Diseases/therapy , Regenerative Medicine , Translational Research, BiomedicalABSTRACT
The New York Stem Cell Foundation's "Fifth Annual Translational Stem Cell Research Conference" convened on October 12-13, 2010 at the Rockefeller University in New York City. The conference attracted over 400 scientists, patient advocates, and stem cell research supporters from 16 countries. In addition to poster and platform presentations, the conference featured panels entitled "Road to the Clinic" and "Regulatory Roadblocks."
Subject(s)
Congresses as Topic , Foundations , Stem Cell Research , Translational Research, Biomedical , Humans , New York City , Stem Cell Research/economics , Stem Cell Research/ethics , Stem Cell Research/legislation & jurisprudence , Stem CellsABSTRACT
Sponsored by the New York Stem Cell Foundation (NYSCF), the "Fourth Annual Translational Stem Cell Research Conference: Breaking Ground" convened October 13-14, 2009 at The Rockefeller University in New York City to discuss translational stem cell research. Attracting over 400 scientists, patient advocates, and stem cell research supporters from fifteen countries, the two-day conference featured an afternoon of panel discussions, intended for a broad audience, followed by a second day of scientific talks and poster presentations. This report summarizes both days of this exciting conference.
